Cargando…
Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma—an analysis of the Cancer Genome Atlas (TCGA) dataset
BACKGROUND: Mitochondrial transcription elongation factor (TEFM) is a key molecule for mitochondrial DNA (mtDNA) replication-transcription switch. TEFM regulates both transcription elongation and RNA processing in mitochondria. However, the expression level and prognostic value of TEFM in low grade...
Autores principales: | Li, Sufen, Wang, Weisi, Zi, Jiaji, Sun, Meitao, Mei, Wen, Yang, Na, Zhang, Ruopeng, Yu, Min, Xiong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798344/ https://www.ncbi.nlm.nih.gov/pubmed/35117724 http://dx.doi.org/10.21037/tcr.2020.04.16 |
Ejemplares similares
-
TEFM is a potent stimulator of mitochondrial transcription elongation in vitro
por: Posse, Viktor, et al.
Publicado: (2015) -
TEFM regulates both transcription elongation and RNA processing in mitochondria
por: Jiang, Shan, et al.
Publicado: (2019) -
Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma
por: Wan, Lixin, et al.
Publicado: (2021) -
Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019) -
TEFM (c17orf42) is necessary for transcription of human mtDNA
por: Minczuk, Michal, et al.
Publicado: (2011)